Clinic News

Latest in Cardiology

Low MAE Rates in Pediatric Patients With Cardiomyopathy Undergoing Cardiac Catheterization | NCDR Study
Pediatric patients with cardiomyopathy undergoing cardiac catheterization had a low rate of major adverse events (MAE) when compared to the general pediatric population, according to a recent study published in JAHA.
CMS Releases 2027 IPPS, Interoperability and Prior Auth Proposed Rules
The Centers for Medicare and Medicaid Services (CMS) released two proposed rules on April 10: the fiscal year 2027 Inpatient Prospective Payment System (IPPS) proposed rule and another on interoperability and prior authorization for drugs for Medicare Advantage organizations and Medicaid Managed Care plans.
Real-World TTVR is Safe, Effective in Patients With Severe TR | NCDR Study
In the first year of its approval in the U.S., transcatheter tricuspid valve replacement (TTVR) in patients with severe tricuspid regurgitation (TR) was found to be safe and effective by STS/ACC TVT Registry data, showing 30-day outcomes consistent with the TRISCEND II pivotal trial...
Eagleâ€™s Eye View: Letâ€™s Examine How We Care For Patients
In this weekâ€™s View, Dr. Eagleâ€¯explores four recent articles that examine how we care for patients. First, Dr. Eagleâ€¯looks at a new state-of-the-art review that outlines a multidisciplinary framework for cardiogenic shock survivorship.
ACCEL Lite: Addressing Cardiovascular-Kidney-Metabolic Syndrome Health
In this interview, Alison L. Bailey, MD, FACC andâ€¯ Chiadi E. Ndumele, MD, PhD discuss Addressing Cardiovascular-Kidney-Metabolic Syndrome Health.
Transcatheter Aortic Valve Implantation: Durability and Management of Valve Failure
Transcatheter aortic valve implantation (TAVI) has become a cornerstone therapy for patients with severe aortic stenosis across a wide spectrum of clinical presentations and surgical risk. Initially reserved for patients at prohibitive or high surgical risk, TAVI is now widely adopted in populations at intermediate and low risk...
ACC Leadership Update: Reflections and Highlights From the March BOT Meeting at ACC.26
I am truly honored to serve as the new president of the ACC. I am excited to work alongside all of you over the coming year as we advance the Collegeâ€™s strategic priorities and continue our shared Mission to transform cardiovascular care for all.
ACC Practice Made Perfect: The Dyad Leadership Model - Foundations for Success
In this kickoff episode sponsored by the CV Management Section, we explore what truly makes a dyad partnership effective in cardiovascular care.
Clinical Practice Algorithm For the Follow-Up of Unrepaired and Repaired Tetralogy of Fallot
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease (CHD). Early management of this condition is typically dictated by the degree of pulmonary stenosis (PS) and resulting oxygen saturations.
Addressing Modifiable Barriers May Improve Access to Quadruple GDMT For Veterans With HFrEF
Addressing modifiable barriers such as medication copays may improve access to care and outcomes for patients with heart failure with reduced ejection fraction (HFrEF), according to a cohort study published April 1 in JAMA Cardiology, which identified significant gaps in the rate and timeliness of quadruple therapy for veterans who are newly diagnosed.